TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $67,000 | +76.3% | 7,000 | +250.0% | 0.01% | +75.0% |
| Q4 2021 | $38,000 | -43.3% | 2,000 | 0.0% | 0.00% | -42.9% |
| Q3 2021 | $67,000 | -14.1% | 2,000 | 0.0% | 0.01% | -22.2% |
| Q2 2021 | $78,000 | -18.8% | 2,000 | 0.0% | 0.01% | -18.2% |
| Q1 2021 | $96,000 | -7.7% | 2,000 | 0.0% | 0.01% | -15.4% |
| Q4 2020 | $104,000 | -78.2% | 2,000 | -88.8% | 0.01% | -80.0% |
| Q3 2020 | $478,000 | +37.4% | 17,850 | 0.0% | 0.06% | +27.5% |
| Q2 2020 | $348,000 | +97.7% | 17,850 | 0.0% | 0.05% | +64.5% |
| Q1 2020 | $176,000 | -43.0% | 17,850 | -35.9% | 0.03% | -27.9% |
| Q4 2019 | $309,000 | +83.9% | 27,850 | -6.7% | 0.04% | +72.0% |
| Q3 2019 | $168,000 | -34.9% | 29,850 | 0.0% | 0.02% | -34.2% |
| Q2 2019 | $258,000 | +7.5% | 29,850 | 0.0% | 0.04% | +5.6% |
| Q1 2019 | $240,000 | +228.8% | 29,850 | +67.2% | 0.04% | +200.0% |
| Q4 2018 | $73,000 | -27.0% | 17,850 | 0.0% | 0.01% | -14.3% |
| Q3 2018 | $100,000 | -57.4% | 17,850 | 0.0% | 0.01% | -62.2% |
| Q2 2018 | $235,000 | -7.1% | 17,850 | 0.0% | 0.04% | -9.8% |
| Q1 2018 | $253,000 | +73.3% | 17,850 | 0.0% | 0.04% | +78.3% |
| Q4 2017 | $146,000 | -31.1% | 17,850 | 0.0% | 0.02% | -32.4% |
| Q3 2017 | $212,000 | +18.4% | 17,850 | 0.0% | 0.03% | +17.2% |
| Q2 2017 | $179,000 | -13.9% | 17,850 | 0.0% | 0.03% | -14.7% |
| Q1 2017 | $208,000 | +150.6% | 17,850 | 0.0% | 0.03% | +126.7% |
| Q4 2016 | $83,000 | -32.5% | 17,850 | +12.6% | 0.02% | -31.8% |
| Q3 2016 | $123,000 | +28.1% | 15,850 | 0.0% | 0.02% | +10.0% |
| Q2 2016 | $96,000 | -11.9% | 15,850 | +23.3% | 0.02% | 0.0% |
| Q1 2016 | $109,000 | -38.4% | 12,850 | -13.5% | 0.02% | -31.0% |
| Q4 2015 | $177,000 | +18.0% | 14,850 | 0.0% | 0.03% | +16.0% |
| Q3 2015 | $150,000 | -35.1% | 14,850 | +6.5% | 0.02% | -26.5% |
| Q2 2015 | $231,000 | 0.0% | 13,950 | -6.7% | 0.03% | 0.0% |
| Q1 2015 | $231,000 | +4.5% | 14,950 | +7.2% | 0.03% | +6.2% |
| Q4 2014 | $221,000 | +84.2% | 13,950 | +24.6% | 0.03% | +88.2% |
| Q3 2014 | $120,000 | – | 11,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |